{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:28:07Z","timestamp":1707524887695},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,23]]},"DOI":"10.7759\/cureus.34107","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T21:59:46Z","timestamp":1674511186000},"source":"Crossref","is-referenced-by-count":0,"title":["Vasovagal Syncope and Pulseless Electrical Activity Cardiac Arrest in Patients With Immunoglobulin Light Chain Cardiac Amyloidosis: A Case Series"],"prefix":"10.7759","author":[{"given":"Brett W","family":"Sperry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed A","family":"Harhash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furha","family":"Cossor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309914","article-title":"Amyloid heart disease: genetics translated into disease-modifying therapy","volume":"103","author":"Sperry BW","year":"2017","unstructured":"Sperry BW, Tang WH. Amyloid heart disease: genetics translated into disease-modifying therapy. Heart. 2017, 103:812-7. 10.1136\/heartjnl-2016-309914","journal-title":"Heart"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-014-9464-5","article-title":"Natural history and therapy of AL cardiac amyloidosis","volume":"20","author":"Grogan M","year":"2015","unstructured":"Grogan M, Dispenzieri A. Natural history and therapy of AL cardiac amyloidosis. Heart Fail Rev. 2015, 20:155-62. 10.1007\/s10741-014-9464-5","journal-title":"Heart Fail Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-308657","article-title":"Prognostic implication of relative regional strain ratio in cardiac amyloidosis","volume":"102","author":"Senapati A","year":"2016","unstructured":"Senapati A, Sperry BW, Grodin JL, et al.. Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart. 2016, 102:748-54. 10.1136\/heartjnl-2015-308657","journal-title":"Heart"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14740\/jh866","article-title":"Current updates on the management of AL amyloidosis","volume":"10","author":"Elsayed M","year":"2021","unstructured":"Elsayed M, Usher S, Habib MH, et al.. Current updates on the management of AL amyloidosis. J Hematol. 2021, 10:147-61. 10.14740\/jh866","journal-title":"J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.96.6.1847","article-title":"Direct vascular effects of furosemide in humans","volume":"96","author":"Pickkers P","year":"1997","unstructured":"Pickkers P, Dormans TP, Russel FG, Hughes AD, Thien T, Schaper N, Smits P. Direct vascular effects of furosemide in humans. Circulation. 1997, 96:1847-52. 10.1161\/01.cir.96.6.1847","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvdsp.2019.01.014","article-title":"Mode of death in cardiac amyloidosis","volume":"11","author":"Kharoubi M","year":"2019","unstructured":"Kharoubi M, Bodez D, Galat A, et al.. Mode of death in cardiac amyloidosis. Arch Cardiovasc Dis Suppl. 2019, 11:288. 10.1016\/j.acvdsp.2019.01.014","journal-title":"Arch Cardiovasc Dis Suppl"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(98)00549-x","article-title":"The North American vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope","volume":"33","author":"Connolly SJ","year":"1999","unstructured":"Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol. 1999, 33:16-20. 10.1016\/s0735-1097(98)00549-x","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.08.026","article-title":"Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN study","volume":"70","author":"Baron-Esquivias G","year":"2017","unstructured":"Baron-Esquivias G, Morillo CA, Moya-Mitjans A, et al.. Dual-chamber pacing with closed loop stimulation in recurrent reflex vasovagal syncope: the SPAIN study. J Am Coll Cardiol. 2017, 70:1720-8. 10.1016\/j.jacc.2017.08.026","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/128871-vasovagal-syncope-and-pulseless-electrical-activity-cardiac-arrest-in-patients-with-immunoglobulin-light-chain-cardiac-amyloidosis-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:34Z","timestamp":1707508654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/128871-vasovagal-syncope-and-pulseless-electrical-activity-cardiac-arrest-in-patients-with-immunoglobulin-light-chain-cardiac-amyloidosis-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,23]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.34107","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,23]]}}}